Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Severe adverse events · patients with initial treatment of HIV infection in antiretroviral‐naive individuals

Co‐formulated abacavir‐lamivudine‐zidovudine showed no clear difference in severe adverse events compared with NNRTIs or PIs (moderate certainty).

1 finding from 1 review

Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS 2013 · Cochrane Headline outcomes only
RR 1.22 [0.78, 1.92]
4 studies · 2247 participants
Moderate